1
Healthcare professionals working within the wider medical community in Sierra Leone have expressed serious concern about the off-licence use of this potentially toxic drug in suspected and confirmed Ebola without the patient's consent. Amiodarone has well documented cardiac, hepatic, and pulmonary side effects.
2 3 Evidence of benefit in Ebola virus disease is speculative at best, and amiodarone is not considered a priority novel drug for Ebola by WHO, further questioning the ethics of its use in the current outbreak. 4 This use of amiodarone, and other unconventional practices-such as the use of high doses of diuretic in Ebola associated acute kidney injury-at Emergency's Ebola treatment centre reaffirms the pressing need for greater accountability and clinical governance of NGOs acting independently in medical disaster situations.
